Results 181 to 190 of about 247,498 (312)
Aims Oral administration of (S)‐ketamine for treatment‐resistant depression (TRD), as alternative to the registered intranasal or off‐label intravenous administrations, has high potential. However, it is characterized by an extensive first‐pass metabolism, resulting in low (S)‐ketamine exposure and high levels of active metabolites, including (S ...
Marije E. Otto +5 more
wiley +1 more source
Septic Thrombophlebitis of the Portal Vein: A Case Report. [PDF]
Ballal M, Ly EJ.
europepmc +1 more source
Portal vein thromboembolism of liver allografts from splenectomized donors. [PDF]
Koneru, B +5 more
core +1 more source
Aim To develop and validate a physiologically‐based pharmacokinetic (PBPK) model enabling inhaled oxytocin dose selection for clinical evaluation. Subsequently, to conduct a phase 1 study investigating the pharmacokinetics and safety of selected doses of an optimized inhaled oxytocin product in healthy, non‐pregnant female participants.
Pete Lambert +6 more
wiley +1 more source
Conservative Management for Postoperative Portal Vein Bleeding: A Case Report. [PDF]
Onishi Y +3 more
europepmc +1 more source
Aims Paediatric pharmacokinetics differ significantly from adults due to age‐related physiological changes, necessitating precise dose adjustments. However, data on therapeutic drug monitoring (TDM) implementation in paediatric setting remain limited.
Gianluca Gazzaniga +20 more
wiley +1 more source
Clinical management of portal vein thrombosis in cirrhosis: an evidence‑based narrative review. [PDF]
Dai K, Hansi N, See TC.
europepmc +1 more source
Fiber‐type soft bioelectronics for wearable and implantable sensing and therapy
Fiber‐type soft bioelectronics are emerging as versatile platforms for wearable and implantable health monitoring and therapeutic applications. These bioelectronics use organic and inorganic matrices combined with advanced fillers, which feature high conductivity, electrochemical sensitivity, softness, and biocompatibility.
Haneul Kim +5 more
wiley +1 more source
Endovascular flow reduction after portal vein arterialization: a technical note. [PDF]
Can E +10 more
europepmc +1 more source

